Astria Therapeutics, Inc.

CIK 1454789 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Astria Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 17, 2026SCHEDULE 13G/A0000902664-26-001087
Feb 12, 2026SCHEDULE 13G/A0001076809-26-000024
Feb 9, 2026SCHEDULE 13D/A0001193125-26-042995
Feb 2, 202615-12G0001140361-26-003219
Jan 28, 2026SCHEDULE 13D/A0001104659-26-007234
Jan 27, 2026EFFECT9999999995-26-000306
Jan 27, 2026EFFECT9999999995-26-000308
Jan 27, 2026EFFECT9999999995-26-000310
Jan 27, 2026EFFECT9999999995-26-000305
Jan 27, 2026EFFECT9999999995-26-000307
Jan 27, 2026EFFECT9999999995-26-000311
Jan 26, 202625-NSE/A0001354457-26-000086
Jan 23, 2026POS AM0001140361-26-002205
Jan 23, 2026S-8 POS0001140361-26-002227
Jan 23, 2026S-8 POS0001140361-26-002230
Jan 23, 202625-NSE0001354457-26-000075
Jan 23, 2026S-8 POS0001140361-26-002224
Jan 23, 2026S-8 POS0001140361-26-002232
Jan 23, 2026S-8 POS0001140361-26-002231
Jan 23, 2026POS AM0001140361-26-002203
Jan 23, 2026POS AM0001140361-26-002204
Jan 23, 202640000905148-26-000320
Jan 23, 2026POS AM0001140361-26-002206
Jan 23, 2026POS AM0001140361-26-002208
Jan 23, 2026S-8 POS0001140361-26-002233